| Kong, Beihua |
EC-01, NCT01820858: The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma |
|
|
| Active, not recruiting | 3 | 300 | RoW | Paclitaxel, Paraplatin (Carboplatin Injection), Pelvic Radiation, Vaginal Brachytherapy 1, Vaginal brachytherapy 2 | Ding Ma, Shandong University, Huazhong University of Science and Technology, Zhejiang University | Endometrial Neoplasms | 12/25 | 12/26 | | |
NCT05737303: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer |
|
|
| Recruiting | 3 | 538 | RoW | nab-paclitaxel combined with carboplatin, paclitaxel combined with carboplatin | Women's Hospital School Of Medicine Zhejiang University, Jiaxing Maternity and Child Health Care Hospital, Zhejiang University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, Sun Yat-sen University, Qilu Hospital of Shandong University, Ningbo No. 1 Hospital, Ningbo Women & Children's Hospital, Sir Run Run Shaw Hospital | Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III, Fallopian Tube Carcinoma Stage IV, Primary Peritoneal Carcinoma Stage III, Primary Peritoneal Carcinoma Stage IV | 12/24 | 12/27 | | |
| Recruiting | 3 | 129 | RoW | Paclitaxel, Anzatax, TAX, Carboplatin, Bleomycin, Blanoxan, BLEO, BLM, Etoposide, ETOP, Etopophos, Cisplatin | Beihua Kong, Huazhong University of Science and Technology, Zhejiang University, Sun Yat-sen University | Ovarian Germ Cell Cancer, Ovarian Neoplasms, Ovarian Cancer | 05/25 | 05/30 | | |
| Recruiting | 3 | 132 | RoW | Paclitaxel, Anzatax, TAX, Carboplatin, Bleomycin, Blanoxan, BLEO, BLM, Etoposide, ETOP, Etopophos, Cisplatin | Beihua Kong, Huazhong University of Science and Technology, Zhejiang University, Sun Yat-sen University | Ovarian Sex Cord Stromal Tumor, Ovarian Neoplasms, Ovarian Cancer | 05/25 | 05/30 | | |
| Active, not recruiting | 2 | 270 | RoW | AK112 | Akeso | Gynecologic Cancer, Cancer Metastatic, Ovarian Neoplasms, Cervical Neoplasm, Endometrial Neoplasms | 05/23 | 05/24 | | |
TQB2858-II-01, NCT05121363: A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma |
|
|
| Not yet recruiting | 2 | 113 | RoW | TQB2858 injection, Anlotinib Hydrochloride capsules | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Carcinoma | 05/23 | 07/23 | | |
NCT04670978: Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer |
|
|
| Recruiting | 2 | 96 | RoW | albumin-bound paclitaxe combined with bevacizumab biosimilar | Shandong University | Objective Response Rate | 12/23 | 12/24 | | |
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
|
|
| Recruiting | 2 | 88 | RoW | RC88, RC88 for Injection | RemeGen Co., Ltd. | Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer | 06/26 | 12/26 | | |
| Recruiting | 2 | 225 | RoW | SHR- A1811 | Jiangsu HengRui Medicine Co., Ltd. | Gynaecological Malignancies | 06/26 | 06/26 | | |
TQB2858-Ⅰ-06, NCT05068921: A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy |
|
|
| Recruiting | 1 | 40 | RoW | TQB2858 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cervical Cancer | 05/23 | 07/23 | | |
NCT04633330: Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female |
|
|
| Recruiting | N/A | 60 | RoW | AHCC®capsules, Yinuojin Ruanjiaonang, Simulation of AHCC®capsules, Yinuojin Ruanjiaonang Moniji | Shandong University, Qilu Hospital of Shandong University | High Risk Human Papillomavirus Infection, Low Grade Squamous Intraepithelial Lesion | 06/24 | 12/24 | | |
| Active, not recruiting | N/A | 240 | RoW | TH, TH/BSO, BPLND | Ding Ma, Shandong University, Huazhong University of Science and Technology, Zhejiang University | Endometrial Neoplasms | 12/25 | 12/26 | | |
| Recruiting | N/A | 590 | RoW | Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy | Women's Hospital School Of Medicine Zhejiang University, Tongji Hospital, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, Sun Yat-sen University, Peking University People's Hospital, Shanghai First Maternity and Infant Hospital, Xiangya Hospital of Central South University, Anhui Provincial Cancer Hospital, Ningbo Women & Children's Hospital, Ningbo No. 1 Hospital | Endometrial Cancer Stage I, Endometrial Cancer Stage II | 12/24 | 01/27 | | |
NCT05883670: Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer |
|
|
| Recruiting | N/A | 118 | RoW | Serplulimab, HLX10 | Shandong University | Cervical Cancer | 03/24 | 12/25 | | |
| CHEN, XIAOJUN |
NCT03675139: MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia |
|
|
| Completed | 3 | 471 | RoW | Medroxyprogesterone Acetate, Provera, Dydrogesterone 10 MG, Duphaston | Xiaojun Chen | Endometrial Hyperplasia Without Atypia | 05/22 | 05/22 | | |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
NCT06379113: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients |
|
|
| Recruiting | 2/3 | 29 | RoW | GnRH antagonist, Letrozole 2.5mg | Xiaojun Chen | Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance, Obesity | 03/25 | 03/25 | | |
NCT06390904: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients |
|
|
| Recruiting | 2/3 | 29 | RoW | GnRH antagonist, Letrozole 2.5mg | Xiaojun Chen | Atypical Endometrial Hyperplasia, Progesterone Resistance, Obesity | 06/25 | 06/25 | | |
NCT05172999: Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia |
|
|
| Recruiting | 2/3 | 28 | RoW | levonorgestrel-releasing intrauterine system, MIRENA, Polyethylene Glycol Loxenatide, Fulaimei, PEX168 | Fudan University | Atypical Endometrial Hyperplasia, Obesity, Fertility Issues | 12/24 | 06/26 | | |
NCT05316467: Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma |
|
|
| Recruiting | 2/3 | 89 | RoW | Intensive Lifestyle Intervention (ILI), Weight Management, Megestrol Acetate 160 MG Oral Tablet, yilizhi | Xiaojun Chen | Endometrial Carcinoma, Obese, Overweight, Fertility Issues | 02/25 | 02/26 | | |
NCT05316493: Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia |
|
|
| Recruiting | 2/3 | 172 | RoW | Intensive Lifestyle Intervention (ILI), Weight Management, Megestrol Acetate 160 MG Oral Tablet, yilizhi, Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg, manyuele | Xiaojun Chen | Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity | 02/25 | 02/26 | | |
NCT05316935: GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients |
|
|
| Recruiting | 2/3 | 80 | RoW | GnRHa, Triprorelin acetate, Letrozole 2.5mg, Diane-35, ethinylestradiol cyproterone, MET | Xiaojun Chen | Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance | 03/25 | 03/25 | | |
NCT05454358: Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP |
|
|
| Recruiting | 2/3 | 299 | RoW | Letrozole 2.5mg, Letrozole 2.5mg qd po for 2 years | Fudan University, Obstetrics & Gynecology Hospital of Fudan University | Endometrial Cancer | 08/28 | 07/30 | | |
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 196 | RoW | TQB2450, Anlotinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer | 12/21 | 04/22 | | |
NCT04836663: A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors |
|
|
| Recruiting | 2 | 90 | RoW | TQ-B3525 tablet | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer | 09/22 | 12/22 | | |
NCT04491643: Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma |
|
|
| Recruiting | 2 | 48 | RoW | Megestrol Acetate, Rosuvastatin | Fudan University | Endometrial Carcinoma Stage I | 08/25 | 08/25 | | |
NCT05247268: Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole in Young Women with Early Endometrial Cancer |
|
|
| Recruiting | 2 | 104 | RoW | Megestrol Acetate 160 MG Oral Tablet, Megestrol Acetate, Medroxyprogesterone Acetate 500 MG, Medroxyprogesterone Acetate, Triprorelin Acetate, Letrozole 2.5mg, Letrozole | Fudan University, Peking Union Medical College Hospital | Endometrial Neoplasm Malignant Stage I | 03/25 | 03/25 | | |
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B |
|
|
| Not yet recruiting | 1/2 | 162 | RoW | TQA3038 injection/placebo, Nucleotide drugs Control group | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatitis B, Chronic | 09/26 | 09/26 | | |
NCT05965128: Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases |
|
|
| Recruiting | N/A | 1255 | RoW | | Huashan Hospital | Respiratory Infectious Diseases | 12/23 | 12/27 | | |
| Recruiting | N/A | 590 | RoW | Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy | Women's Hospital School Of Medicine Zhejiang University, Tongji Hospital, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, Sun Yat-sen University, Peking University People's Hospital, Shanghai First Maternity and Infant Hospital, Xiangya Hospital of Central South University, Anhui Provincial Cancer Hospital, Ningbo Women & Children's Hospital, Ningbo No. 1 Hospital | Endometrial Cancer Stage I, Endometrial Cancer Stage II | 12/24 | 01/27 | | |
NCT05998720: Application of New Magnetic Resonance UTE Technique in Hip Joint Lesions |
|
|
| Recruiting | N/A | 150 | RoW | | Fifth Affiliated Hospital, Sun Yat-Sen University | Hip Disease | 06/24 | 06/24 | | |
NCT05998707: The Application of the New Magnetic Resonance UTE Technique in Thoracic Lesions |
|
|
| Recruiting | N/A | 150 | RoW | | Fifth Affiliated Hospital, Sun Yat-Sen University | Lung Diseases | 06/24 | 06/24 | | |
NCT04276532: Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus |
|
|
| Recruiting | N/A | 780 | RoW | sentinel lymph node sampling (SLN), pelvic lymphonodectomy (PLN) | Xiaojun Chen, Fudan University, Tongji Hospital, West China Second University Hospital, Sun Yat-sen University, Chongqing University Cancer Hospital | Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis | 02/25 | 02/28 | | |
| Yu, Kang |
| Recruiting | 3 | 225 | Europe, Canada, Japan, US, RoW | Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B) | F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi | Invasive Aspergillosis | 09/25 | 11/26 | | |
| Completed | 2 | 150 | US, RoW | Paclitaxel, Afuresertib, LAE002 | Laekna Limited | Platinum-resistant Ovarian Cancer | 07/23 | 06/24 | | |
NCT05716087: A Study of Rocbrutinib in Participants with Relapse or Refractory Mantle Cell Lymphoma |
|
|
| Recruiting | 2 | 62 | RoW | Rocbrutinib, NWP-775, LP-168 | Guangzhou Lupeng Pharmaceutical Company LTD. | Mantle Cell Lymphoma (MCL) | 12/24 | 12/25 | | |
NCT04003168: Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma |
|
|
| Recruiting | 1 | 18 | RoW | Human BCMA targeted T Cells Injection | Hrain Biotechnology Co., Ltd., Shanghai Changzheng Hospital, First Affiliated Hospital of Wenzhou Medical University, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine | Multiple Myeloma | 07/22 | 07/24 | | |
NCT03302403: Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors |
|
|
| Active, not recruiting | N/A | 18 | RoW | CAR-CD19 T cell, CD19-redirected Autologous Cell, CAR-BCMA T cell, BCMA-redirected Autologous Cell, CAR-GPC3 T cell, GPC3-redirected Autologous Cell, CAR-CLD18 T cell, Claudin18.2-redirected Autologous Cell, Fludarabine, Cyclophosphamide | Kang YU, CARsgen Therapeutics Co., Ltd. | B Cell Lymphoma, B Cell Leukemia, Myeloma, Hepatocellular Carcinoma, Pancreatic Carcinoma, Adenocarcinoma of Esophagogastric Junction | 12/20 | 12/23 | | |
NCT04690075: Effect of Dietary Fiber on Metabolism, Inflammation and Nutritional Status in Patients With Chronic Diseases |
|
|
| Recruiting | N/A | 120 | RoW | Nutrition Management and Dietary Fiber, Nutrition Management | Peking Union Medical College Hospital | Chronic Disease, Dietary Fiber | 04/21 | 06/21 | | |
NCT04550806: Glycated Albumin Combined With Body Composition for Gestational Diabetes Mellitus Prediction |
|
|
| Recruiting | N/A | 300 | RoW | | Peking Union Medical College Hospital | Gestational Diabetes Mellitus in Pregnancy | 06/21 | 07/21 | | |
NCT05015348: Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia |
|
|
| Not yet recruiting | N/A | 120 | NA | fish oil with omega-3 PUFA, placebo | Peking Union Medical College Hospital | Hyperlipidemias | 12/21 | 01/22 | | |
NCT06380777: Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia |
|
|
| Recruiting | N/A | 10000 | RoW | | Peking Union Medical College Hospital | Sarcopenia | 12/28 | 12/28 | | |
NCT05771207: Effects of Protein on Muscle, Gut Microbiota and Clinical Outcome in Patients With Lung Cancer-related Sarcopenia |
|
|
| Not yet recruiting | N/A | 90 | RoW | soy protein, whey protein, placebo | Peking Union Medical College Hospital | Lung Cancer, Sarcopenia | 10/23 | 01/24 | | |
NCT05802381: the Safety and Effectiveness of Protein Supplements on Cancer Patients With Nutritional Risk and Malnutrition |
|
|
| Not yet recruiting | N/A | 100 | NA | protein supplement, protein, nutrition counseling | Peking Union Medical College Hospital | Cancer, Malnutrition | 04/24 | 12/24 | | |
NCT06347835: Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis |
|
|
| Not yet recruiting | N/A | 120 | RoW | symbiotic, whey protein, symbiotic placebo, whey protein placebo | Peking Union Medical College Hospital | Sarcopenia | 04/25 | 01/26 | | |
NCT06453057: Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours |
|
|
| Recruiting | N/A | 18 | RoW | GT307 injection | Grit Biotechnology | Adult | 06/27 | 06/27 | | |
NCT04594863: The Investigation of the Mechanism of Cachexia Occurrence for Patients With Gastrointestinal Cancer |
|
|
| Not yet recruiting | N/A | 100 | RoW | | Peking Union Medical College Hospital | Cachexia | 05/21 | 06/21 | | |
| Zhang, Yu |
NCT06506838: Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma |
|
|
| Recruiting | 4 | 39 | RoW | Anlotinib | Guangdong Provincial People's Hospital | Soft Tissue Sarcoma, Doxorubicin, Radiotherapy | 07/27 | 07/28 | | |
| Not yet recruiting | 4 | 336 | RoW | Danning Tablet, Biliflow (NPN 80073325, manufactured by Shanghai Hutchison Pharmaceuticals Limited) | Eastern Hepatobiliary Surgery Hospital | Polyps Gallbladder | 08/24 | 11/24 | | |
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A |
|
|
| Completed | 3 | 750 | RoW | ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273 | Guangdong Raynovent Biotech Co., Ltd | Influenza A | 04/23 | 05/23 | | |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
| Recruiting | 3 | 516 | RoW | Tirofiban, Tirofiban Hydrochloride and Sodium Chloride Injection, Aspirin tablet, Clopidogrel tablet | Peking Union Medical College Hospital, Pharmaron (Chengdu) Clinical Services Co., Ltd. | Branch Atheromatous Disease | 07/25 | 10/25 | | |
| Active, not recruiting | 3 | 90 | Europe, Canada, US, RoW | Pimicotinib(ABSK021), Placebo | Abbisko Therapeutics Co, Ltd | Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath | 05/26 | 06/28 | | |
| Recruiting | 2/3 | 440 | RoW | Camrelizumab, Cisplatin, Nab paclitaxel, Radical surgery, external beam radiation therapy (EBRT) + brachytherapy | Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University General Hospital, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital, Cancer Hospital of Guangxi Medical University | Cervical Cancer, Locally Advanced Cervical Cancer, Concurrent Chemoradiotherapy, Neoadjuvant Chemoimmunotherapy | 03/31 | 03/31 | | |
TQB3616-ALTN-II-01, NCT04924192: A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer |
|
|
| Recruiting | 2 | 126 | RoW | TQB3616 capsules, Anlotinib Hydrochloride capsules, Irinotecan Hydrochloride for Injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Lung Carcinoma | 05/23 | 12/23 | | |
NCT05148195: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors |
|
|
| Terminated | 2 | 86 | RoW | Envofolimab, BD0801, Docetaxel, Irinotecan, Leucovorin calcium, 5-Fluorouridine | Jiangsu Simcere Pharmaceutical Co., Ltd. | Advanced Solid Tumor | 07/23 | 07/23 | | |
NCT05765825: Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC |
|
|
| Recruiting | 2 | 61 | RoW | serplulimab, HLX10, Cisplatin, Cisplatin injection, Carboplatin, Carboplatin injection, Etoposide, Etoposide injection, Thoracic radiation therapy (TRT), low-dose radiotherapy | Sichuan University | Extensive-stage Small-cell Lung Cancer | 06/24 | 12/25 | | |
NCT06251947: Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen |
|
|
| Recruiting | 2 | 83 | RoW | Efbemalenograstim Alfa | Shandong University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Ovarian Cancer, Cervical Cancer | 06/26 | 12/26 | | |
NCT06434610: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. |
|
|
| Recruiting | 2 | 90 | RoW | B013, Paclitaxel, Placebo | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Platinum-resistant Recurrent Ovarian Cancer | 12/26 | 12/26 | | |
| Recruiting | 2 | 40 | RoW | Camrelizumab, SHR-1210, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, radical surgery | Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Gansu Provincial Maternal and Child Health Care Hospital, Beijing Friendship Hospital, Tianjin Medical University General Hospital, Xiangya Hospital of Central South University, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Zhejiang Cancer Hospital, Shengjing Hospital, Qilu Hospital of Shandong University, Cancer Hospital of Guangxi Medical University | Cervical Cancer, Locally Advanced Cervical Cancer, PD-L1 Negative, Neoadjuvant Chemoimmunotherapy | 12/25 | 12/30 | | |
NCT06014190: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer |
|
|
| Recruiting | 2 | 460 | RoW | HS-20089 | Hansoh BioMedical R&D Company | Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer | 12/25 | 12/27 | | |
NCT04202003: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
|
|
| Completed | 1/2 | 105 | RoW | TJ011133 | TJ Biopharma Co., Ltd. | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes(MDS) | 12/23 | 12/23 | | |
|
|
NCT05767866: Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR |
|
|
| Recruiting | 1/2 | 160 | RoW | YK-029A | Suzhou Puhe Pharmaceutical Technology Co., LTD | Treatment, Treatment Side Effects | 12/23 | 05/24 | | |
NCT06118788: Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1/2 | 24 | RoW | BG1805 | Guangzhou Bio-gene Technology Co., Ltd | Leukemia, Myeloid, Acute | 03/25 | 07/25 | | |
NCT05416775: Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 1/2 | 168 | RoW | SHR-8068；Adebrelimab, SHR-8068；adebrelimab and platinum-based chemotherapy, Adebrelimab；platinum-based chemotherapy | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Advanced Non-small Cell Lung Cancer | 06/26 | 06/26 | | |
NCT05788159: An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions. |
|
|
| Not yet recruiting | 1 | 16 | RoW | Lacosamide Tablets, Lacosamide extended release tablets | Overseas Pharmaceuticals, Ltd., Beijing Capton Pharmaceutical Technology Development Co., LTD | Epilepsy | 06/23 | 07/23 | | |
NCT06387082: A Clinical Study of HMPL-506 in Patients With Hematological Malignancies |
|
|
| Recruiting | 1 | 98 | RoW | HMPL-506, Two strengths of HMPL-506 tablets (25 mg and 100 mg) will be used for this clinical study | Hutchmed | Hematological Malignancies | 10/27 | 12/27 | | |
NCT06412458: IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma |
|
|
| Not yet recruiting | 1 | 9 | RoW | IM83 CAR-T Cells | Beijing Immunochina Medical Science & Technology Co., Ltd., Guangdong Provincial People's Hospital | Refractory Osteosarcoma, Recurrent Osteosarcoma | 06/25 | 06/26 | | |
NCT06662760: Clinical Trial of TQB3002 in Patients With Advanced Cancers |
|
|
| Not yet recruiting | 1 | 120 | RoW | TQB3002 Tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cancer | 10/25 | 10/26 | | |
NCT05151133: Clinical Study of Allergic Rhinitis Therapy by Stem Cells |
|
|
| Recruiting | 1 | 18 | RoW | Low dose UCMSCs, Moderate dose UCMSCs, High dose UCMSCs | Yantai Yuhuangding Hospital | Allergic Rhinitis | 12/24 | 12/24 | | |
APG-115-AC101, NCT04275518: A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. |
|
|
| Recruiting | 1 | 102 | RoW | APG-115, Azacitidine, Cytarabine | Ascentage Pharma Group Inc., Suzhou Yasheng Pharmaceutical Co., Ltd. | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) | 12/25 | 12/25 | | |
NCT04173832: Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine |
|
|
| Recruiting | N/A | 100 | RoW | Tianqi Pingchan Granule Combined With Amantadine, Placebo Combined With Amantadine | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Wenzhou Central Hospital, The Affiliated Hospital of Qingdao University, Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, The Affiliated Hospital of Xuzhou Medical University | L-DOPA-Induced Dyskinesia | 12/20 | 12/21 | | |
NCT05233917: Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome |
|
|
| Completed | N/A | 240 | RoW | Olive oil use, MLCT oil use | Zhejiang University | Hyperlipidaemia, Metabolic Syndrome | 12/23 | 12/23 | | |
EBPS, NCT04809025: Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer |
|
|
| Recruiting | N/A | 510 | RoW | endoscopy, Surgery | Fudan University | Stomach Neoplasms, Endoscopy, Biopsy, Pathology | 04/23 | 04/24 | | |
PNFS, NCT05247632: Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study |
|
|
| Active, not recruiting | N/A | 2290 | RoW | | Zhejiang University, Lanxi Red Cross Hospital, Lanxi Hospital of Traditional Chinese Medicine | Chronic Diseases | 05/24 | 07/28 | | |
NCT06039735: Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma |
|
|
| Recruiting | N/A | 50 | RoW | Chemotherapy and/or autologous hematopoietic stem cell transplantation | Qilu Hospital of Shandong University | Multiple Myeloma | 11/23 | 12/28 | | |
NCT06512207: A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer |
|
|
| Recruiting | N/A | 80 | RoW | Leuprorelin acetate + Sintilimab, Leuprolide, Sintilimab, Anti-PD-1 monoclonal | Jinzhou Medical University, The First Affiliated Hospital of Zhengzhou University | NSCLC, Stage III, NSCLC, Stage IV | 12/25 | 06/26 | | |
| Recruiting | N/A | 590 | RoW | Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy | Women's Hospital School Of Medicine Zhejiang University, Tongji Hospital, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, Sun Yat-sen University, Peking University People's Hospital, Shanghai First Maternity and Infant Hospital, Xiangya Hospital of Central South University, Anhui Provincial Cancer Hospital, Ningbo Women & Children's Hospital, Ningbo No. 1 Hospital | Endometrial Cancer Stage I, Endometrial Cancer Stage II | 12/24 | 01/27 | | |
NCT06276309: Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors |
|
|
| Recruiting | N/A | 300 | RoW | | Fujian Maternity and Child Health Hospital | Neuroendocrine Neoplasm, China, Women, Cervical Cancer, Cervical Lesion | 12/24 | 02/25 | | |
NCT05932576: A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women |
|
|
| Recruiting | N/A | 12000 | RoW | | Fujian Maternity and Child Health Hospital | Human Papillomavirus Vaccines, Efficacy, Self, Adverse Effect, China, Woman | 12/24 | 12/24 | | |
NCT05932563: Study on the Epidemiological Characteristics of Female HPV Vaccination in China |
|
|
| Recruiting | N/A | 1700 | RoW | | Fujian Maternity and Child Health Hospital | Human Papillomavirus Vaccines, Adverse Effect, Epidemiology, China, Woman | 12/24 | 12/24 | | |
| Sun, Li |
NCT04908865: Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) |
|
|
| Active, not recruiting | 4 | 67 | RoW | Belimumab, Standard therapy | GlaxoSmithKline | Systemic Lupus Erythematosus | 05/24 | 09/24 | | |
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease |
|
|
| Recruiting | 4 | 1312 | RoW | GV-971, Placebo | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer's Disease | 06/29 | 12/29 | | |
HER2CLIMB-02, NCT03975647: A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer |
|
|
| Active, not recruiting | 3 | 466 | Europe, Canada, Japan, US, RoW | tucatinib, ONT-380, placebo, T-DM1, Kadcyla | Seagen Inc. | HER2-positive Breast Cancer | 06/23 | 10/27 | | |
|
|
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin |
|
|
| Active, not recruiting | 3 | 551 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | Type 2 Diabetes Mellitus | 03/25 | 12/25 | | |
NCT06145893: A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease |
|
|
| Recruiting | 3 | 162 | RoW | Hemay005, Mufemilast, Phosphodiesterase 4 (PDE4) inhibitors, Placebo | Ganzhou Hemay Pharmaceutical Co., Ltd | Behçet's Disease | 11/24 | 03/25 | | |
NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer |
|
|
| Active, not recruiting | 3 | 274 | RoW | BPI-16350, placebo, Fulvestrant | Betta Pharmaceuticals Co., Ltd. | Breast Cancer | 12/23 | 07/25 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 196 | RoW | TQB2450, Anlotinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer | 12/21 | 04/22 | | |
NCT04830644: A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. |
|
|
| Recruiting | 2 | 144 | RoW | Iguratimod, Placebo | Jiangsu Simcere Pharmaceutical Co., Ltd. | Primary Sjögren Syndrome | 04/22 | 06/22 | | |
NCT06180889: Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty |
|
|
| Recruiting | 2 | 240 | RoW | Enoxaparin, KN060 Low, KN060 Middle, KN060 Hight | Suzhou Alphamab Co., Ltd. | Knee Arthroplasty, Total | 12/25 | 04/26 | | |
NCT06250062: A Clinical Study of JS005 in Patients With Ankylosing Spondylitis |
|
|
| Recruiting | 2 | 261 | RoW | Recombinant humanized IL-17A Monoclonal Antibody（JS005）, Placebo（JS005） | Shanghai Junshi Bioscience Co., Ltd., Sponsor GmbH | Ankylosing Spondylitis | 02/25 | 10/25 | | |
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
|
|
| Recruiting | 2 | 88 | RoW | RC88, RC88 for Injection | RemeGen Co., Ltd. | Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer | 06/26 | 12/26 | | |
NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer |
|
|
| Recruiting | 2 | 64 | RoW | GT101 injection, Gemcitabine injection | Grit Biotechnology | Adult | 01/27 | 01/27 | | |
NCT06315231: Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients |
|
|
| Recruiting | 2 | 80 | RoW | Edaravone dexborneol sublingual tablet, Placebo | Simcere Pharmaceutical Co., Ltd | Post-stroke Cognitive Impairment | 12/25 | 12/25 | | |
NCT06251947: Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen |
|
|
| Recruiting | 2 | 83 | RoW | Efbemalenograstim Alfa | Shandong University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Ovarian Cancer, Cervical Cancer | 06/26 | 12/26 | | |
| Suspended | 2 | 279 | Europe, US, RoW | zetomipzomib, KZR-616, placebo, matching placebo | Kezar Life Sciences, Inc. | Lupus Nephritis | 05/26 | 07/26 | | |
TQB2858-Ⅰ-06, NCT05068921: A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy |
|
|
| Recruiting | 1 | 40 | RoW | TQB2858 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cervical Cancer | 05/23 | 07/23 | | |
NCT06420154: The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases |
|
|
| Not yet recruiting | 1 | 9 | RoW | anti-CD19-CAR-T cells | First Affiliated Hospital of Wenzhou Medical University, Shanghai First Song Therapeutics Co., Ltd | Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Systemic Sclerosis, Inflammatory Myopathy, ANCA Associated Vasculitis, Antiphospholipid Syndrome | 05/27 | 05/27 | | |
| Recruiting | 1 | 216 | RoW | BAT8006 for Injection, Exatecan conjugate of recombinant humanized monoclonal antibody against folate receptor α for injection | Bio-Thera Solutions | Advanced Solid Tumors | 12/24 | 12/25 | | |
